Liquid Chromatography Tandem Mass Spectrometry (LC-MS/MS) Method for the Determination of Vildagliptin in Rat Plasma

被引:10
作者
Sakthimanigandan, K. [1 ]
Ganesh, M. [2 ]
Kanthikiran, V. S. [3 ]
Sivakumar, T. [4 ]
Jang, H. T. [2 ]
机构
[1] Alkem Labs Ltd, Taloja 410208, Maharashtra, India
[2] Hanseo Univ, Dept Chem Engn, Seoson 360706, Chungcheongnam, South Korea
[3] Dr Reddys Labs Ltd, Hyderabad 500072, Andhra Pradesh, India
[4] Nandha Coll Pharm, Erode 638052, Tamil Nadu, India
关键词
Vildagliptin; LC/MS/MS; rat plasma; MRM; PEPTIDASE-IV; DEGRADATION;
D O I
10.1556/AChrom.27.2015.2.7
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
A new sensitive and validated liquid chromatography electro spray ion-tandem mass spectrometry (HPLC-ESI-MS/MS) method for the quantification of Vildagliptin (VG) in rat plasma has been developed and validated using repaglinide (RG) as an internal standard (IS). The analytes were extracted by liquid-liquid extraction using ethyl acetate. Elution of the VG and IS was achieved on a reverse phase Betasil (C18 50 mm 4.6 mm ID, 5 mu) column with an isocratic mobile phase composed of acetonitrile: 2 mM ammonium acetate (90: 10 v/v). The analytes monitored in the Multiple Reaction Monitoring (MRM) mode were m/z 304.2 -> 154.0 and 453.3 -> 230.3 for VG and RG, respectively. The calibration curve was linear in the range of 1.57-501.21 ng/mL for VG with lower limit of quantification 1.57 ng/mL. The intra run and inter run precision values are within 11.70% for VG at LOQ level.
引用
收藏
页码:295 / 307
页数:13
相关论文
共 12 条
[1]  
Ahren B., 2006, Curr. Opin. Endocrinol. Diabetes, V13, P154, DOI DOI 10.1097/01.MED.0000216964.28881.BA
[2]  
[Anonymous], 2001, GUID IND BIOAN METH
[3]   Stability-Indicating RP-LC Method for the Determination of Vildagliptin and Mass Spectrometry Detection for a Main Degradation Product [J].
Barden, Amanda Thomas ;
Salamon, Barbara ;
Sherman Schapoval, Elfrides Eva ;
Steppe, Martin .
JOURNAL OF CHROMATOGRAPHIC SCIENCE, 2012, 50 (05) :426-432
[4]   Circulation and degradation of GIP and GLP-1 [J].
Deacon, CF .
HORMONE AND METABOLIC RESEARCH, 2004, 36 (11-12) :761-765
[5]  
El-Bagary Ramzia I, 2011, Int J Biomed Sci, V7, P55
[6]  
El-Bagary Ramzia I, 2011, Int J Biomed Sci, V7, P201
[7]   Simultaneous identification and validated quantification of 11 oral hypoglycaemic drugs in plasma by electrospray ionisation liquid chromatography-mass spectrometry [J].
Hess, Cornelius ;
Musshoff, Frank ;
Madea, Burkhard .
ANALYTICAL AND BIOANALYTICAL CHEMISTRY, 2011, 400 (01) :33-41
[8]   Dipeptidyl-Peptidase IV from Bench to Bedside: An Update on Structural Properties, Functions, and Clinical Aspects of the Enzyme DPP IV [J].
Lambeir, AM ;
Durinx, C ;
Scharpé, S ;
De Meester, I .
CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES, 2003, 40 (03) :209-+
[9]   Dipeptidyl-peptidase IV (CD26)-role in the inactivation of regulatory peptides [J].
Mentlein, R .
REGULATORY PEPTIDES, 1999, 85 (01) :9-24
[10]  
Pharne AB., 2012, INT J PHARM PHARM SC, V4, P119